The incidence of colorectal carcinoma (CRC) in transplant (TX) recipients is higher than in the general population.
Registry data indicate inferior oncological outcomes for this population.
While the general surgical risk is increased in TX recipients, the risk associated with elective CRC surgery in this population is not well investigated.
